1. Significance of Molecular and Cytogenetic TP53 Status in MDS with Complex Karyotypes. (April 2017) Authors: Ganster, C.; Schaab, R.; Shirneshan, K.; Dierks, S.; Martin, R.; Germing, U.; Palomo, L.; Mies, A.; Cisneros, A.; Braulke, F.; Hildebrandt, B.; Kaivers, J.; Platzbecker, U.; Kroeger, N.; Doehner, K.; Glass, B.; Nickelsen, M.; Schanz, J.; Bacher, U.; Haase, D. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Targeted Deep Sequencing of Peripheral CD34+ Cells can Reproduce Bone Marrow Molecular Profile in MDS Patients. (April 2017) Authors: Acha, P.; Martin, R.; Palomo, L.; Ganster, C.; Dierks, S.; Mallo, M.; Ademà, V.; Fuster-Tormo, F.; Gómez-Marzo, P.; De Haro, N.; Jiménez-García, F.; Solanes, N.; Zamora, L.; Xicoy, B.; Kominowski, A.; Stromburg, M.; Brockmann, A.; Truemper, L.; Sole, F.; Haase, D. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗